Sunmax Biotechnology Co., Ltd. (TPEX:4728)

Sunmax Biotechnology Revenue

Sunmax Biotechnology had revenue of 503.60M TWD in the quarter ending September 30, 2025, with 10.07% growth. This brings the company's revenue in the last twelve months to 2.00B, up 14.55% year-over-year. In the year 2024, Sunmax Biotechnology had annual revenue of 1.82B with 7.64% growth.

• Revenue (ttm): 2.00B
• Revenue Growth: +14.55%
• P/S Ratio: 10.66
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 21.30B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.82B	129.03M	7.64%
Dec 31, 2023	1.69B	288.91M	20.64%
Dec 31, 2022	1.40B	364.42M	35.19%
Dec 31, 2021	1.04B	179.81M	21.01%
Dec 31, 2020	855.85M	261.71M	44.05%